⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2047455 | 0.65 | — | — | |
| SCHEMBL15885867 | 0.55 | — | — | |
| SCHEMBL2047456 | 0.53 | — | — | |
| SCHEMBL9596236 | 0.45 | — | — | |
| SCHEMBL348913 | 0.41 | AHR (0.67) | — | |
| SCHEMBL6513247 | 0.38 | — | — | |
| SCHEMBL5792991 | 0.36 | AHR (0.47) | — | |
| SCHEMBL13197717 | 0.36 | AHR (0.53) | — | |
| SCHEMBL10017669 | 0.35 | — | — | |
| SCHEMBL15029211 | 0.35 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3893872-B1 | ORGANOPHOSPHORUS-SUBSTITUTED COMPOUNDS AS C-MET INHIBITORS AND THERAPEUTIC USES THEREOF | BETA PHARMA INC (US) | 2024-07-17 | — | — | EP | disclosed |